Daniel D. Pinschewer
Founder en Hookipa Biotech AG .
Perfil
Daniel D.
Pinschewer is the founder of Hookipa Biotech AG (2011) and HOOKIPA Pharma, Inc. (2011).
At HOOKIPA Pharma, Inc., he held the title of Chief Scientific Officer from 2017 to 2019.
Dr. Pinschewer's former jobs include being a Professor at the University of Basel and an Associate Professor at the University of Geneva from 2007 to 2013.
Dr. Pinschewer received his undergraduate degree from the University of Zurich Medical School.
Cargos activos de Daniel D. Pinschewer
| Empresas | Cargo | Inicio |
|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Founder | 01/07/2011 |
Antiguos cargos conocidos de Daniel D. Pinschewer.
| Empresas | Cargo | Fin |
|---|---|---|
| HOOKIPA PHARMA INC. | Founder | 31/12/2019 |
| University of Geneva | Corporate Officer/Principal | 01/01/2013 |
| University of Basel | Corporate Officer/Principal | - |
Formación de Daniel D. Pinschewer.
| University of Zurich Medical School | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HOOKIPA PHARMA INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel D. Pinschewer
